Archive for December 2022
MassDevelopment’s biggest funding recipients in 2022
The state agency MassDevelopment funded 356 projects in fiscal 2022, according to its annual report issued this week. The agency is a major player in a range of economic development projects. Check out the largest projects above. Read More
Read MoreBoston sees its first new major lab proposal in months
Developer Ron Druker is seeking to put a two-building complex in the South End, near another of his lab-and-office projects that already has BPDA approval. Read More
Read MoreSouthwest expects to resume Friday schedule with ‘minimal disruptions’
Boston Logan’s fifth-largest carrier is telling passengers on scheduled flights that it is resuming a full schedule Friday, even as more than three-quarters of its scheduled Thursday flights were canceled. Read More
Read MoreHealey team taps Paige Scott Reed of Prince Lobel Tye for chief legal counsel
Paige Scott Reed has held key legal roles at MassDOT and MBTA. She’ll be the first Black woman to serve as chief legal counsel. Read More
Read MoreEditorial: FDA, don’t bog down cranberry sales
BBJ editorial: The U.S. Food and Drug Administration, in the name of promoting better health nationwide, has proposed a rule that would not only be counterproductive, but could hurt Massachusetts farmers. Read More
Read MoreHere are the Massachusetts companies that raised the largest Series A rounds in 2022
Check out the top 10 Series A deals for Massachusetts startups, including lists for life science and non-life science companies. Read More
Read MoreThe Largest IPOs in Massachusetts of 2022
This list is based on data concerning the largest initial public offerings of Massachusetts-based/co-headquartered companies, as obtained from public filings and BBJ research, as of Nov. 30, 2022. "Amount raised" refers to the gross proceeds from the offering at the time the pricing of the company’s IPO was announced. List does not include publicly traded…
Read MoreThe Petri Dish: Group eyes Biogen Alzheimer’s drug price, FDA rejects psych drug application
The FDA has elected not to accept a new drug application from Minerva Neurosciences Inc., sending shares plummeting. Read this, and more, in the latest biotech news roundup, The Petri Dish. Read More
Read MoreBiotechs and VCs 2022: Top life sciences deals of the past year
While venture capital activity didn’t soar to the heights of 2021, several Boston-area biotechs were able to cinch top dollars from private investment firms. Read More
Read MorePay was a big challenge in 2022. It’s likely 2023 will bring more of the same.
From increasing salary expectations to pay transparency pushes, pay was a big challenge in 2022. Experts say 2023 will bring more of the same. Read More
Read More